NZMA Home

Table of contents
Current issue
Search journal
Archived issues
NZMJ Obituaries 1887-2008
Classifieds
Hotline (free ads)
How to subscribe
How to contribute
How to advertise
Contact Us
Copyright
Other journals
The New Zealand Medical Journal

 Journal of the New Zealand Medical Association, 23-August-2002, Vol 115 No 1160

Establishing a regional diabetes register and a description of the registered population after one year
Kirsten Coppell and Patrick Manning, for the Otago Diabetes Team
Abstract
Aim To establish a regional diabetes register in order to determine baseline data with which to monitor diabetes care in Otago, New Zealand.
Methods All general practitioners (GPs) in Otago were invited to participate in the project. Diabetic patients were identified from GP diabetes registers and invited to participate in the project. Written consent was obtained before any data were transferred from general practices to the Otago Diabetes Register. An Access-based computer programme was developed to record and analyse patient data.
Results In 1998, 1693 consenting diabetic patients were enrolled on the Otago Diabetes Register. The ratio of male to female patients was almost 1:1; the median age was 67 years; 11.9% had Type 1 diabetes and 86.5% had Type 2 diabetes; 44.5% were treated with hypoglycaemic tablets only and 25.6% were treated with insulin only. For those aged over 16 years, the mean systolic BP was 140.6 mmHg and the mean diastolic BP was 78.7 mmHg. 65.4% had undergone a retinal examination within the previous two years and 36.2% a feet examination within the previous year.
Conclusions The 1998 data will be used to monitor changes in diabetic care over time. Ongoing patient recruitment and data collections will also assist with informing funding decisions for diabetes services and improving diabetes information in New Zealand.

Diabetes service delivery is often less than ideal. Recognised barriers to adequate diabetes care include: poor collaboration between general practitioners (GPs) and specialists; variable overall GP care of people with diabetes; variable overall diabetes management; and an historical belief amongst some health workers that non-insulin dependent diabetes is a ‘mild illness’ with few long-term problems.1–4
The Otago Diabetes Team (ODT) was established in 1996 to look at ways to improve diabetes service delivery in the short term and to reduce diabetes-related morbidity and mortality in the Otago region. Limited knowledge about diabetes care amongst GPs and practice nurses was identified as a key barrier to appropriate diabetes management (unpublished report by ODT, March 1997). This finding informed a project plan. The key components of the project were to: establish or update general practice diabetes registers; develop and implement guidelines for the management of core aspects of diabetes care;5 organise GP and practice nurse education; and establish a regional diabetes register in order to monitor diabetes care and evaluate the project. This paper describes how the Otago Diabetes Register was established and the enrolled diabetic population after one year.

Methods

All GPs in the Otago region were invited to participate in the ODT project. GPs were informed that the project involved: establishing or updating general practice diabetes registers; organising education sessions for GPs and practice nurses; developing and implementing guidelines for the management of core aspects of diabetes care; discharging patients from secondary care diabetes clinics who could be appropriately cared for in primary care and establishing a regional diabetes register.
A project nurse established or updated general practice diabetes registers. Identifying diagnosed diabetic patients in general practices was facilitated by GPs recalling any of their diabetic patients from memory, and obtaining lists of GP’s patients who had undergone an HbA1c or fructosamine test, or a retinal photograph within the previous 12 months from the community laboratory and retinal screening department, respectively. The number of diagnosed diabetic patients registered with each GP was unknown, but the number of people with diagnosed diabetes in Otago (4800) was estimated using the 1996 census data and a South Auckland prevalence study.6
Identified diabetic patients were sent an invitation from their GP to participate in the project, along with an explanatory pamphlet, a consent form and a stamped addressed envelope for return of the form. Consent was also obtained opportunistically, when patients attended their general practice. The consent form included questions about ethnicity, smoking status and whether eye or feet examinations had been performed in the preceding 12 months.
Data collected from general practice medical records included: demographic details; type of diabetes and year of diagnosis; dates and results of retinal and feet examinations; diabetes complications; diabetes medication; and dates and results of biochemistry tests. If data were not readily identified in the medical notes, no extra effort was made to find them, except in the case of those patients who had attended either the Dunedin Hospital outpatient diabetes clinic or eye department. If patients’ diabetes type was uncertain, this was checked with the Dunedin Hospital diabetes clinic.
Data were entered into an Access-based programme and Access was used to analyse them.
Ethical approval was obtained from the Southern Regional Health Authority Ethics Committee.

Results

Almost all GPs in Otago accepted the invitation to participate in the project, but not all were visited in the first year. During 1998, 90 of 135 (66.7%) GPs were visited, and 1693 consenting diabetic patients enrolled on the Otago Diabetes Register. There were 867 females (51.2%) and 826 (48.8%) males. Ages ranged from 4 to 97 years and the median age was 67 years. Figure 1 shows the age distribution of registered diabetic patients. Two thirds (66.7%) were aged 60 years and over. Most people were European (91.5%). Few identified as being Maori (2.3%), Pacific (1.2%), or belonging to ‘Other’ ethnic groups including Chinese, Lebanese and Indian (1.8%). Fifty five people did not state their ethnicity. About 40% had never smoked, 44.5% were ex-smokers and 13.5% were current smokers. Smoking status was unknown for 1.3%. Most people (86.5%) had Type 2 diabetes, 11.9% had Type 1 diabetes, 1.1% had secondary diabetes and 0.5% had had gestational diabetes, but not developed Type 2 diabetes.
Overall, about one quarter (26.3%) used diet only to control their diabetes; one quarter (25.6%) used insulin only; almost one half (44.5%) took oral hypoglycaemics only; and a few (3.5%) used both insulin and oral hypoglycaemics. An ACE inhibitor was prescribed for almost one third (32.3%), and lipid-lowering medication was prescribed for 12.4%.
Figure 1. The proportion of registered diabetic patients in each 10-year age group

CONTENT01.jpg

Table 1 shows that 91% of patients had a blood pressure (BP) measurement and 90% had an HbA1c result recorded in their medical notes within 12 months prior to the audit date. Almost 70% had a recent weight measurement recorded. A retinal examination (either photography or fundoscopy by an ophthalmologist) within two years prior to the audit date was recorded for 65.4% patients. Height, feet examination and urine albumin:creatinine ratio tests were performed less frequently: 24.2%, 36.2% and 39.8% respectively.

Table 1. Number and proportion of patients who underwent process measures within specified time intervals prior to audit date

Process measure
Time interval audited
Number of patients (%)
Height*
Weight
Blood pressure
Feet examination
Eye examination
HbA1c
Total cholesterol
Urine albumin:creatine ratio
-
1 year
1 year
1 year
2 years
1 year
1 year
1 year
409 (24.2)
1168 (69.0)
1548 (91.4)
613 (36.2)
1108 (64.6)
1522 (89.9)
853 (50.4)
675 (39.8)
*For children and teenagers, the time interval audited was one year

1159 patients aged over 16 years had their weight recorded and the range was 34 – 181 kg. Amongst those with Type 2 diabetes, the mean weights for males (n=490) and females (n=531) were 87.8 kg and 78.7 kg, respectively. 1543 patients aged over 16 years had a BP measurement recorded. The mean systolic BP was 140.6 mmHg and the mean diastolic BP was 78.7 mmHg. 41% had a systolic BP >140 mmHg and 32% had a diastolic BP >80 mmHg. Of the 1522 patients tested, 50.1% had an HbA1c result greater than 7%. The mean HbA1c for Type 1 and Type 2 patients was 8.8% and 7.2%, respectively. For 853 patients who had lipid tests, the mean levels for total cholesterol, high density lipoprotein (HDL) cholesterol and triglycerides were 5.94 mmol/L, 1.23 mmol/L and 2.17 mmol/L, respectively. Of 675 patients who had a urine albumin:creatinine ratio test, 40% had a result greater than 3.

Discussion

It was estimated that about one third of diagnosed diabetic patients in Otago enrolled on the Register during 1998. While the Register was not complete after one year, this was not unexpected. Not all GPs were visited during the first year, and the completeness of general practice diabetes registers was unknown. The method of sending the consent form with an invitation from the person’s GP, an information pamphlet about the project and a stamped envelope, facilitated the enrolment process well, but up to 25% of invited patients did not respond. The reasons for this were unknown, and the characteristics of these patients were not examined. Nevertheless, the characteristics of the Otago Diabetes Register population at the end of one year were similar to other predominantly European diabetes audit and register populations. The age distribution was similar to a recent Christchurch audit.7 In that study, the median age was 65 years, compared with 67 years for the 1998 Otago Register population. For both these populations, the proportion of people aged over 75 years was 22%. In Otago, 29% of registered patients were using insulin compared with 27% in both the Christchurch audit7 and the DARTS project, Tayside Scotland.8
Type 2 diabetic patients using insulin only were often misclassified in medical notes as having insulin-dependent diabetes mellitus (IDDM) or Type 1 diabetes. Efforts were made to correct identified errors, but some misclassification may persist. This is likely to be small, as the proportions of registered Otago patients with Type 1 diabetes (11.9%) and Type 2 diabetes (86.5%) were similar to the DARTS project population, in which 11.1% had Type 1 diabetes and 88.9% had Type 2 diabetes.9
Good diabetes management requires regular monitoring of parameters such as blood pressure and HbA1c, and retinal screening in order to reduce the risk, and progression, of complications.5 These monitoring tests are not always done. Where the audit interval was the same, the proportions of patients having these checks in Otago were similar to those in the Christchurch audit study.7 While there were large differences in the proportions having feet examinations (Otago 36.2%; Christchurch 66%) and lipid tests (Otago 50.4%; Christchurch 63%), this is most likely due to the Christchurch study audit interval for both these parameters being two years, as opposed to the one-year audit interval in Otago.
HbA1c should ideally be less than 7%.5 In Otago, the same HbA1c assay was used at both laboratories. For 1998, the mean HbA1c was 7.4%. This was similar to that of the second pass audit in Christchurch (7.3%),7 but higher than the 6.9% reported by PrimeHealth.10 It was unknown whether the PrimeHealth population was comparable to the Otago registered diabetic population or whether the HbA1c assay differed.
There is increasing evidence to suggest that good blood pressure control and good lipid profiles are also important in diabetes management in order to prevent the onset and progression of macrovascular complications.11 In 1998, the proportion of registered patients who had undergone a blood pressure check within the previous 12 months was high (91.4%), and comparable to the Christchurch audit (92%).7 While the mean diastolic and systolic blood pressures were good, 32% of patients had a diastolic blood pressure >80 mmHg, and 41% had a systolic >140 mmHg. Because only half of the registered diabetic patients had lipids tested within the previous year, the mean total cholesterol level (5.94 mmol/L) may not be representative of the registered population. Nevertheless, this was comparable to that found in the Christchurch first pass audit (5.84 mmol/L).7
The method of establishing general practice diabetes registers and the Otago Diabetes Register in the first year was systematic and reasonably successful. While the Register was not complete, the enrolled population after one year appeared to be fairly representative of a predominantly European diabetic population. Due to this, and checks to ensure data were as accurate as possible, the results presented probably give a reasonable description of the diagnosed diabetic population in Otago and the care received by these patients in 1998. This project and the ongoing recruitment of patients on to the regional diabetes register will facilitate the monitoring of changes in diabetes care in Otago, and assist with informing health service funding decisions and improving diabetes information in New Zealand.12
Author information: Members of the Otago Diabetes Team were: Ray Anton, Kirsten Coppell, Ron Craft, John Gillies, Sherry Lilley, Patricia McKewen, Patrick Manning, Tim Medlicott, Dean Millar-Coote, Pauline Mumm, Eleanor Murphy, Elizabeth Newsham-West, John Rutherford and Maree Steele.
Acknowledgements: We thank all GPs, practice nurses and diabetic patients who participated in the Otago Diabetes Project. We also acknowledge Ruth Gardener, Gavin Hendry, Robin Versteeg and Sandra Christie, former members of the Otago Diabetes Team, who made significant contributions during the early phases of this project.
Correspondence: Dr Kirsten Coppell, Department of Preventive and Social Medicine, University of Otago, P O Box 913, Dunedin. Fax: (03) 479 7164; email: kirsten.coppell@stonebow.otago.co.nz
References:
  1. Berger M, Viktor J, Flatten G. Health care for persons with non-insulin dependent diabetes mellitus. Ann Intern Med 1996;124:153–5.
  2. Hiss RG. Barriers to Care in non-insulin-dependent diabetes mellitus. The Michigan experience. Ann Intern Med 1996; 124: 146–8.
  3. Keen H. Management of non-insulin-dependent-diabetes. The United Kingdom experience. Ann Intern Med 1996;124:156–9.
  4. Quickel KE. Diabetes in a managed care system. Ann Intern Med 1996;124:160–3.
  5. New Zealand Guidelines Group. Primary Care Guidelines for the Management of core Aspects of Diabetes. Wellington: New Zealand Guidelines Group; June 2000.
  6. Simmons D, Gatland B, Fleming C, et al. Prevalence of known diabetes in a multiethnic community. NZ Med J 1994;107:219–22.
  7. Kendall D, Lunt H, Moore MP, McSweeney W. Diabetes complication screening in general practice: a two pass audit with benchmarking. NZ Med J 1999;112:141–5.
  8. Boyle DIR, MacAlpine R, Newton RW, et al. Achieving St Vincent: electronic record linkage of medical records to monitor population based diabetes care – the DARTS Study. Diab Nutr Metab 1998;11:49.
  9. Morris AD, Boyle DIR, MacAlpine R, et al. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic linkage to create a diabetes register. BMJ 1997;315:524–8.
  10. Aiken J, McArley D. Diabetes complication screening. NZ Med J 1999;112:435.
  11. UK Prospective Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713–20.
  12. Wilson N, Mansoor O, Simmons D. Diabetes in New Zealand – better information needed. NZ Med J 1999;112:206–8.


     
Current issue | Search journal | Archived issues | Classifieds | Hotline (free ads)
Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals